0000899243-16-023480.txt : 20160623
0000899243-16-023480.hdr.sgml : 20160623
20160623160741
ACCESSION NUMBER: 0000899243-16-023480
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160621
FILED AS OF DATE: 20160623
DATE AS OF CHANGE: 20160623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001114220
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 134087132
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 750 LEXINGTON AVENUE
STREET 2: .
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-531-5965
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morrison Jodie Pope
CENTRAL INDEX KEY: 0001618247
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30929
FILM NUMBER: 161728723
MAIL ADDRESS:
STREET 1: C/O TOKAI PHARMACEUTICALS, INC.
STREET 2: ONE BROADWAY, 14TH FLOOR
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-06-21
0
0001114220
KERYX BIOPHARMACEUTICALS INC
KERX
0001618247
Morrison Jodie Pope
C/O KERYX BIOPHARMACEUTICALS, INC.
ONE MARINA PARK DRIVE, 12TH FLOOR
BOSTON
MA
02210
1
0
0
0
Stock Options (right to buy)
6.05
2016-06-21
4
A
0
50000
0.00
A
2017-06-21
2026-06-21
Common Stock
50000
50000
D
The 50,000 stock options vest as follows: 16,667 on June 21, 2017; 16,667 on June 21, 2018; 16,666 on June 21, 2019.
/s/ Brian Adams, Attorney-in-Fact
2016-06-23